Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction

International Journal of Cardiology

Volumn 101, Issue 3, 2005, Pages 347-353

  Žaliunas, Remigijus ^a   Braždžionyte, Julija ^a   Zabiela, Vytautas ^a   Jurkevičius, Renaldas ^b  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Arterial hypertension; Calcium channel blockers; Coronary artery disease; Heart rate variability

Indexed keywords

AMLODIPINE; LACIDIPINE;

ADRENERGIC SYSTEM; ADULT; AGED; ANKLE EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FLUSHING; HEART LEFT VENTRICLE FAILURE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SIDE EFFECT; SINGLE BLIND PROCEDURE; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; VAGUS NERVE STIMULATION;

ADULT; AGED; AMLODIPINE; ANGINA PECTORIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; DIHYDROPYRIDINES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 19344367319     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.03.040     Document Type: Article

References (46)

1. P.K. Stein, M.S. Bosner, R.E. Kleger, and B.M. Conger Heart rate variability: a measure of cardiac autonomic tone Am. Heart J. 127 1994 1376 1381
2. B. Wennerblom, L. Lurje, and H. Tygesen Patients with uncomplicated coronary artery disease have reduced heart rate variability mainly affecting vagal tone Heart 83 2000 290 294
3. K. Kohara, W. Nishida, and M. Maguchi Autonomic nervous function in non-diper essential hypertensive subjects Hypertension 26 1995 808
4. R. Krittayaphong, W.E. Cascio, and K.C. Light Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores Psychosom. Med. 59 1997 231 235
5. C.M.A. Van Ravenswaaij-Arts, L. Kolle, and J. Hopman Heart rate variability Ann. Intern. Med. 118 1993 436 447
6. M.R. Cowie, D.A. Wood, and A.J.S. Coats Incidence and aetiology of heart failure Eur. Heart J. 20 1999 421 428
7. F.M. Baer, and E. Erdmann The clinical manifestation and relevance of diastolic dysfunction Dialogues Cardiovasc. Med. 4 4 1999 183 197
8. W. Grossman Defining diastolic dysfunction Circulation 101 17 2000 2020
9. M. Senni, C.M. Tribouilloy, and R.J. Rodeheffer Congestive heart failure in the community: a study of all incident cases in Olmsted Country, Minnesota in 1991 Circulation 98 21 1998 2282 2289
10. R.J.M. De Vries, P.H.J.M. Dunselman, and U.G. Sung Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure Heart 75 1996 159 164
11. D.R. Abernethy, and J.B. Schwartz Drug therapy: calcium-antagonist drugs N. Engl. J. Med. 341 1999 1447 1457
12. M. Epstein Role of third generation calcium antagonist in the management of hypertension Drugs 57 Suppl. 1 1999 1 10
13. C.P. Lau, and B.M. Cheung Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind study J. Cardiovasc. Pharmacol. 28 2 1996 328 331
14. A. Zanchetti Lacidipine 1997 Adis International Milan
15. K. Sakata, M. Shirotani, and H. Yoshida Effects of amlodipine and clinidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension Hypertension 33 1999 1447 1452
16. R.J.M. De Vries, and P.H.J.M. Dunselman The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine J. Cardiovasc. Pharmacol. 25 3 1995 S33 S39
17. D. Lucini, P. Strappazzon, and F. Colombo Maintained autonomic responses to moderate exercise in hypertensive patients treated with lacidipine J. Hypertens. 15 1997 1751 1754
18. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability. Standards of measurement, physiological interpretation, and clinical use Eur. Heart J. 17 1996 354 381
19. E. Kristal-Boneh, M. Raifel, and P. Froom Heart rate variability in health and disease Scand. J. Work, Environ. Health 21 1995 85 95
20. P.K. Stein, S. Bosner, and R. Kleiger Heart rate variability: a measure of cardiac autonomic tone Am. Heart J. 127 1994 1376 1381
21. P.K. Stein, and R.E. Kleiger Insights from the study of heart rate variability Annu. Rev. Med. 50 1999 249 261
22. C.M.A. Van Ravenswaaij-Arts, L. Kolle, and J. Hopman Heart rate variability Ann. Intern. Med. 118 1993 436 447
23. H.V. Huikuri Heart rate variability in coronary artery disease J. Int. Med. 237 1995 349 357
24. C.D. Kuo, and G.Y. Chen Heart rate variability standards Circulation 98 15 1998 1589 1590
25. K. Wachtell, J.N. Bella, and P.R. Liebson Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study Hypertension 35 2000 6 12
26. W.J. Remme The sympathetic nervous system and ischaemic heart disease Eur. Heart J. 19 Suppl. F 1998 F62 F71
27. B. Wennerblom, L. Lurje, and H. Tygesen Patients with uncomplicated coronary artery disease have reduced heart rate variability mainly affecting vagal tone Heart 83 2000 290 294
28. S. Julius Sympathetic hyperactivity and coronary risk in hypertension Hypertension 21 1993 886 893
29. K. Sakata, M. Shirotani, H. Yoshida, and C. Kurata Comparison of effects of enalaprili and nitrendipine on cardiac sympathetic nervous system in essential hypertension J. Am. Coll. Cardiol. 32 1998 438 443
30. D. Zhemaityte Heart rate variability and cardiovascular pathology 1999 Kaunos Medical Academy Palanga
31. E. Grossman, and F.H. Messerli Effect of calcium antagonists on sympathetic activity Eur. Heart J. 19 Suppl. F 1998 F27 F31
32. T. Hamada, M. Watanabe, and T. Kaneda Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine J. Hypertens. 16 1998 111 118
33. J. de Champlain, M. Karas, and P. Nguyen Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients J. Hypertens. 16 1998 1357 1369
34. G. Grassi, D. Spaziani, and G. Seravalle Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure Hypertension 33 1999 671 675
35. R. Fogari, A. Zoppi, and L. Corradi Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension J. Hypertens. 18 2000 1871 1875
36. Y. Sirenko, V. Radchenko, and V. Granich Assessment of long-acting calcium antagonists (nitrendipine, lacidipine, nifedipine) in treatment of arterial hypertension J. Hypertens. 18 2 2000 s154
37. D. Acanfora, L. Trojano, and M. Gheorghiade A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability Am. J. Ther. 9 5 2002 444 453
38. J. Minami, T. Ishimitsu, and Y. Kagano Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients Clin. Exp. Pharmacol. Physiol. 25 1998 572 576
39. I. Ragueneau, A.B. Sao, and C. Funk-Brentan Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers Clin. Pharmacol. Ther. 69 2001 122 129
40. F. Leenen, and A. Fourney Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass Am. J. Cardiol. 78 2 1996 203 207
41. P. Hjemdahl Plasma catecholamines: analytical challenges and physiological limitations Baillere's Clin. Endocrinol. Metab. 7 1993 307 353
42. L. Forslund, I. Bjorkander, and M. Ericson Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris Heart 87 2002 415 422
43. S. Julius Corcoran lecture. Sympathetic hyperactivity and coronary risk in hypertension Hypertension 21 1993 886 893
44. M. Ruzicka, and F.H.H. Leenen Relevance of 24 h blood pressure profile and sympathetic activity for outcome on short- versus long-acting 1,4-dihydropyridines Am. J. Hypertens. 6 1996 86 94
45. H.V. Barron, and M.D. Lesh Autonomic nervous system and sudden cardiac death J. Am. Coll. Cardiol. 27 1996 1053 1060
46. Y. Pardo, B. Noel, and M. Paul-Labrador Heart rate variability reproducibility and stability using commercially available equipment in coronary artery disease with daily life myocardial ischaemia Am. J. Cardiol. 78 1996 866 870